 COPENHAGEN, Denmark, Jan. 12, 2021 GLOBE NEWSWIRE -- Forward Pharma AS NASDAQ:FWP we, Forward or the Company, today announced that due to ongoing precautionary measures against the spread of the novel coronavirus COVID-19, the Technical Board of Appeal the TBA of the European Patent Office the EPO again has rescheduled the oral hearing of the appeal against the decision of the Opposition Division that revoked the EP2801355 patent the 355 Patent. The new hearing date is set for September 6, 2021. 